• Respiratory Therapy

    07 October 2026
    Why the US is betting millions on this Aussie antiviral nasal spray

    View news

  • Respiratory Therapy

    07 October 2026
    Volunteers Wanted: NMRC Clinical Trials Center Prepares for Phase 2 Trial of Respiratory Illness Treatment

    View news

  • Respiratory Therapy

    01 September 2026
    Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial

    View news

  • Vaccine

    2 April 2026
    Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions

    View article

  • NBC Washington

    25 February 2026
    Nasal spray could prevent respiratory viruses

    Watch video

  • PharmaTimes

    29 January 2026
    ENA Respiratory begins dosing in phase 2 study of INNA-051 nasal spray

    View news

  • BioCentury

    5 January 2026
    ENA Respiratory: Boosting prophylactic immunity with a pan-viral nasal spray

    View PDF

  • Financial Review

    27 October 2025
    Bill Gates, Brandon Capital back Aussie flu-fighting start-up

    View article [Behind paywall]

  • PharmaTimes

    22 October 2025
    ENA Respiratory secures US$22.4m to advance nasal spray therapy

    View news

  • The Pharma Letter

    18 December 2024
    Airing in journal a further step forward for ENA Respiratory

    View news

  • BiotechDispatch

    10 September 2024
    ENA Respiratory secures extension of US funding for novel prophylactic antiviral

    View news

  • Brandon Capital Website

    7 May 2024
    Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential

    View news

  • Forbes

    12 September 2023
    It beat the Covid virus, so why did this Aussie startup get $12m from the US military to start over?

    View article

  • Respiratory Therapy

    1 May 2022
    Antiviral Nasal Spray Being Developed by ENA Respiratory, COPD Foundation

    View article

  • Fierce Pharma

    28 February 2022
    COPD Foundation links arms with ENA on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu

    View article

  • Fierce Biotech

    13 February 2022
    ENA slices data to claim flu success in phase 2 and nasal spray’s wide-ranging potential

    View article

  • Fierce Pharma

    22 June 2021
    ENA Respiratory raises $24M to trial COVID-19 nasal spray

    View article

  • Pharmafile

    18 December 2020
    ENA Respiratory’s nasal spray reduces COVID-19 replication by 96%

    View article

  • BioWorld

    29 September 2020
    ENA Respiratory launches with AU$11.7M series A as it heads toward clinic with COVID-19 nasal spray

    View article [behind a paywall]

  • The Standard

    28 September 2020
    Weekly nasal spray could offer protection from Covid-19, research finds

    View article